<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/Registration.aspx?ReturnURL=%2Fgen-news-highlights%2Fmiragen-secures-exclusive-license-to-in-vivo-applications-of-t2cure-s-mir-92-ip%2F81244299%2F%3Fkwrd%3DmiRagen>